Medical Device

🍜 Success Stories of Real-World Data (Part 2)

How Hainan became China’s medtech pilot zone

🍜 NMPA Approval with Real-World Data

What If Your Clinical Data Isn't Enough?

🍜 China's Online E-Commerce

When online specs meet medical device compliance rules

🍜 China's New Risk Rules

NMPA Draft Could Up-Class Your Device

🍜 Future of Medical Device Industry in China (Part 2)

🍜 Future of China's Medical Device Industry (Part 1)

🍜 EU-China Tension Over Medical Device Procurement

What it means for global supply chains

🍜Journey of Innovative Medical Devices

What makes China’s pathway different from the US?

🍜 China’s 2025 Update on Clinical Evaluation Exemption

Is your device on the list?

🍜 China PMS (Part 3): Reassessment Rules Explained

When, what, and how you must report to NMPA

🍜 Post-market Surveillance (Part 2)

🍜 Potential Changes to China's Medical Device Classification Rules

New draft rules sharpen the line between Class I and Class II devices